Healthcare costs of Type 2 diabetes in Germany

Aim To describe for the first time the direct costs of Type 2 diabetes treatment by analysing nationwide routine data from statutory health insurance in Germany. Methods This cost‐of‐illness‐study was based on a 6.8% random sample of all German people with statutory health insurance (4.3 out of 70 m...

Full description

Saved in:
Bibliographic Details
Published in:Diabetic medicine Vol. 34; no. 6; pp. 855 - 861
Main Authors: Jacobs, E., Hoyer, A., Brinks, R., Icks, A., Kuß, O., Rathmann, W.
Format: Journal Article
Language:English
Published: England Wiley Subscription Services, Inc 01.06.2017
Subjects:
Adult
Aged
Aged, 80 and over
Data processing
Dentists
Diabetes
Diabetes mellitus
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - economics
Diabetes Mellitus, Type 2 - epidemiology
Drug stores
Female
Germany - epidemiology
Group health insurance
Health Care Costs
Health care expenditures
Health care policy
Health Resources - economics
Health Resources - statistics & numerical data
Hospitalization - economics
Hospitalization - statistics & numerical data
Hospitals
Humans
Insurance, Health
Male
Middle Aged
National Health Programs
Per capita
Pharmacy
ISSN:0742-3071, 1464-5491, 1464-5491
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aim To describe for the first time the direct costs of Type 2 diabetes treatment by analysing nationwide routine data from statutory health insurance in Germany. Methods This cost‐of‐illness‐study was based on a 6.8% random sample of all German people with statutory health insurance (4.3 out of 70 million people). The healthcare expenses show direct per capita costs from the payer perspective. Healthcare expenses for physicians, dentists, pharmacies, hospitals, sick benefits and other healthcare costs were considered. Per capita costs, cost ratios for people with Type 2 diabetes and without diabetes as well as diabetes‐attributable costs were calculated. Results Per capita costs for people with Type 2 diabetes amounted to €4,957 in 2009 and €5,146 in 2010. People with Type 2 diabetes had 1.7‐fold higher health expenses than people without diabetes. The largest differences in health expenses were found for prescribed medication from pharmacies (cost ratio diabetes/no diabetes: 2.2) and inpatient treatment (1.8). Ten percent of the total statutory health insurance expense, in total €16.1 billion, was attributable to the medical care of people with Type 2 diabetes. Conclusions This nationwide study indicates that one in 10 Euros of healthcare expenses is spent on people with Type 2 diabetes in Germany. In the future, national statutory health insurance data can be used to quantify time trends of costs in the healthcare system. What's new? This is the first cost‐of‐illness study that is based on a representative 6.8% random sample of all 70 million people insured in the German statutory health insurance system. Direct per capita costs for physicians, dentists, pharmacies, hospitals, sick benefits and other healthcare expenses were calculated. Costs for sick benefits and dental care were examined for the first time. The analysis showed that one in 10 Euros of healthcare expenses is spent on people with Type 2 diabetes (€16.1 billion) in Germany. The health expenses for people with Type 2 diabetes were 1.7‐fold higher than for people without diabetes.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0742-3071
1464-5491
1464-5491
DOI:10.1111/dme.13336